Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03214029 · ClinicalTrials.gov registry record
COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial
A clinical trial of Acute Coronary Syndrome and Acute Myocardial Infarction, sponsored by Hennepin Healthcare Research Institute.
- Active
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT03214029 is a study of Acute Coronary Syndrome and Acute Myocardial Infarction that is active but no longer recruiting, run by Hennepin Healthcare Research Institute. The registered enrollment target is 2,000 participants, below the 2,672-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03214029, a study of Acute Coronary Syndrome and Acute Myocardial Infarction, is active but no longer recruiting, sponsored by Hennepin Healthcare Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Compare the analytical and clinical performance of hs-cTnI and hs-cTnT assays for the diagnosis of acute myocardial injury and myocardial infarction in patients presenting to the emergency department in whom serial cTnI measurements are obtained on clinical indication.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Cardiac troponin testing
Study Locations (1)
Minnesota
- Hennepin County Medical Center - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2017-11-06 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03214029
The ClinicalTrials.gov registry entry for NCT03214029 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,672-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (25% lower). The listed sponsor is Hennepin Healthcare Research Institute, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Acute Coronary Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Cardiac troponin testing is the first listed.
NCT03214029 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03214029 about?
NCT03214029 is a clinical study titled "COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial". Compare the analytical and clinical performance of hs-cTnI and hs-cTnT assays for the diagnosis of acute myocardial injury and myocardial infarction in patients presenting to the emergency department in whom serial cTnI measurements are obtained on clinical indication.
What is the current status of trial NCT03214029?
This trial is currently active not recruiting. The enrollment target is 2,000 participants. The study started on 2017-11-06. Estimated completion is 2025-12-31.
What conditions does trial NCT03214029 study?
This clinical trial studies the following conditions: Acute Coronary Syndrome, Acute Myocardial Infarction.
What interventions are being tested in trial NCT03214029?
The interventions under investigation include: Cardiac troponin testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03214029?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03214029 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Coronary Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Polypill for Acute Coronary Syndrome
RECRUITING · Phase 2
-
Positive Emotions Following Acute Cardiac Events
RECRUITING · NA
-
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
RECRUITING
-
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
RECRUITING · Phase 3
-
A Prospective Research Investigation of Ischemia Using MCG
RECRUITING
-
AngelMed Guardian® System PMA Post Approval Study
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.